Category: Articles

The UPC’s First FRAND Decision: What the Dolby v. Beko Ruling Means for SEP Licensing Negotiations

The Swiss Federal Patent Court’s Expedited Nullity Proceedings: What It Means for Pharma and MedTech IP Portfolios

The Rise of NPE Litigation: Why Non-Practicing Entities Are Targeting Mid-Market Companies — and How Proactive Infringement Monitoring Changes Your Defence

Why This Is Now One of the Most Valuable Patent Licensing Markets in the World — and How to Build a Strategy for It

If Your Server Is Overseas but Your Users Aren’t, You May Already Be Infringing: What the Supreme Court Ruling Means for SaaS and Software Companies

How the Unified Patent Court Is Reshaping Patent Landscape Analysis for European R&D Teams

China’s New Patent Invalidation Rules in 2026: How the ‘Substantially Same Evidence’ Standard Changes Your Defence Strategy

The First SEP Injunction in History: What It Means for Technology Companies Implementing Wireless Standards

China’s Patent Examination Overhaul: What the New 2026 CNIPA Guidelines Mean for Your IP Portfolio

What Three Years of UPC Litigation Data Reveal About Patent Infringement Risk in Europe

Load More